AFC Gamma stock rises on stronger-than-expected distributable earnings

日本 ニュース ニュース

AFC Gamma stock rises on stronger-than-expected distributable earnings
日本 最新ニュース,日本 見出し
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

AFC Gamma Inc. shares rose 3.8% in premarket trades after the debt provider to cannabis companies posted better-than-expected distributable earnings. AFC...

AFC Gamma Inc.

shares rose 3.8% in premarket trades after the debt provider to cannabis companies posted better-than-expected distributable earnings. AFC Gamma said its fourth-quarter net income fell to $2.94 million, or 14 cents a share, from $7 million, or 43 cents a share, in the year-ago quarter. Distributable earnings rose to $12.62 million, 62 cents a share, from $8.5 million, or 52 cents a share, in the year-ago quarter.

shares rose 3.8% in premarket trades after the debt provider to cannabis companies posted better-than-expected distributable earnings. AFC Gamma said its fourth-quarter net income fell to $2.94 million, or 14 cents a share, from $7 million, or 43 cents a share, in the year-ago quarter. Distributable earnings rose to $12.62 million, 62 cents a share, from $8.5 million, or 52 cents a share, in the year-ago quarter.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

MarketWatch /  🏆 3. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

MO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO | Complete Altria Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
続きを読む »

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsBioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trialsShares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...
続きを読む »

Proxy advisors urge shareholders to reject Ritchie Bros bid for IAAProxy advisors urge shareholders to reject Ritchie Bros bid for IAAProxy advisory firms Institutional Shareholder Services and Glass Lewis on Monday recommended that shareholders reject Ritchie Brothers Auctioneers Inc's planned $7 billion acquisition of U.S. auto retailer IAA Inc .
続きを読む »

Meta must face trial over AI trade secrets, judge saysMeta must face trial over AI trade secrets, judge saysMeta Platforms Inc lost a bid on Monday to end a lawsuit in Boston federal court claiming it stole confidential information from artificial-intelligence startup Neural Magic Inc.
続きを読む »

Altria to buy e-cigarette startup NJOY for $2.8 bln after Juul exitAltria to buy e-cigarette startup NJOY for $2.8 bln after Juul exitAltria Group Inc said on Monday it would buy e-cigarette startup NJOY Holdings Inc for about $2.75 billion in cash, in fresh bets by the Marlboro maker on the fast-growing market after losing billions through its investment in Juul.
続きを読む »

Altria to light up vaping push with $2.8 bln NJOY bid after Juul fiascoAltria to light up vaping push with $2.8 bln NJOY bid after Juul fiascoAltria Group Inc said on Monday it would buy e-cigarette startup NJOY Holdings Inc for about $2.75 billion in cash, in a fresh bet by the Marlboro maker on the e-cigarette market after losing billions through its investment in Juul.
続きを読む »



Render Time: 2025-03-04 15:47:28